Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120,538,577
-
Total 13F shares
-
865,615
-
Share change
-
-944,854
-
Total reported value
-
$1,376,000
-
Put/Call ratio
-
42%
-
Price per share
-
$1.59
-
Number of holders
-
15
-
Value change
-
-$905,812
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) as of Q3 2022
As of 30 Sep 2022 REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 865,615 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, CITADEL ADVISORS LLC, RAYMOND JAMES & ASSOCIATES, SABBY MANAGEMENT, LLC, SIMPLEX TRADING, LLC, and JANE STREET GROUP, LLC.
This table shows 15 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.